Characteristics of apathy in clinical forms of Parkinson’s disease
Objective: To study the severity of PD in clinical forms. Background: Apathy is one of the most common symptoms in Parkinson's disease (PD), which can…Longitudinal Analysis of Cognitive Changes in Parkinson’s Disease Subjects at Risk of Developing Probable REM Sleep Behavior Disorder (RBD)
Objective: To characterize the cognitive profile of Parkinson’s Disease (PD) patients that develop probable REM sleep behavior disorder (pRBD) within 8 years after PD diagnosis…Parkinson disease subtype stability and eventual convergence
Objective: To determine the longitudinal stability of Parkinson disease (PD) subtype membership. Background: Previous research demonstrates distinct PD subtypes of “motor only”, “psychiatric & motor”,…Mortality Trends Associated with Parkinson’s Disease with Diabetes Mellitus in the United States (1999-2020)
Objective: To assess the mortality trends and disparities associated with Parkinson’s disease in diabetic patients in the U.S. Background: Parkinson's disease (PD) is the second…Improving Diagnosis of Dementia in Parkinson’s Disease: PDCogniCare Australian Program
Objective: PDCogniCare program aims to improve the utility of cognitive evaluation for earlier and effective diagnosis of mild cognitive impairment and dementia in Parkinson's disease…Refining a Claims-Based Severity Rating Scale for Parkinson’s Disease Using Machine Learning
Objective: This project aimed to develop an advanced claims-based algorithm to assign severity level to people with Parkinson’s (PwP) to enhance research on disease progression.…Assessment of the Applicability of the King and PD-PCS Scales in Patients with Parkinson’s Disease and Chronic Pain: a Pilot Study
Objective: To assess the feasibility of comparing the King's Pain Disease Pain Scale (KING) and The Parkinson's Disease Pain Classification System (PD-PCS) in patients with…Co-occurrence of Parkinson Disease and Myasthenia Gravis in Hospitalized Patients: A Nationwide Analysis
Objective: To investigate the prevalence of Parkinson disease and myasthenia gravis co-occurrence among hospitalized patients in the United States. Background: Parkinson disease (PD), a largely…PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease
Objective: To pilot the 2-step PREDIGT Score model for feasibility and improve it by simplifying both steps. Background: We previously demonstrated that the original PREDIGT…Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease
Objective: Olfactory dysfunction is highly prevalent and often precedes motor symptoms, making it a potential early biomarker for disease progression and cognitive decline in Parkinson's…
- « Previous Page
- 1
- …
- 69
- 70
- 71
- 72
- 73
- …
- 436
- Next Page »